Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing

The astute wealth connected Pfizer (NYSE: PFE) is sending a quieter awesome than the fiscal property typically rewards: organization analysts are constructive, insiders are not transacting successful size successful either direction, and the dividend output is doing the dense lifting. With shares astatine $26.21 and a Wall Street statement people of $29.19, the lack of insider selling into an 11.0% one-year rally is the information constituent retail investors should weigh.

What the Sell Side Actually Says

Coverage connected Pfizer is wide and divided, leaning toward cautious optimism. On average, analysts urge holding shares, and they person a $29.19 statement terms target. Recent actions overgarment the aforesaid picture: UBS held astatine $27 target, pending the Sigvotatug Phase III readout successful mid-2026. Bank of America raised its people to $27 aft the Q1 beat, and Citi reiterated its Hold standing astatine $27.

The composite sentiment work corroborates the expert posture. One crowd-intelligence people stands astatine 65 (Bullish, Medium Confidence), unchanged implicit the past 30 days. That shows nary panic, nary euphoria, conscionable a unchangeable organization presumption that the franchise is worthy holding done the catalyst calendar.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and Pfizer wasn't 1 of them. Get them present FREE.

Insider positioning implicit the past 3 months besides reinforces this view. CEO Albert Bourla made 7 abstracted acquisitions of Phantom Stock Units betwixt March and May 2026 astatine prices ranging from $25.33 to $28.08, and connected April 23, 2026, 13 directors simultaneously acquired Phantom Stock Units astatine $26.67. Crucially, these are deferred compensation accruals tied to committee wage structures alternatively than open-market condemnation buys. On the merchantability side, the lone dispositions came from SVP and Controller Jennifer Damico, totaling 1,481 shares crossed 2 transactions, accordant with taxation withholding connected vesting awards. In large pharma, insider sells of that size astir ever bespeak 10b5-1 program executions oregon taxation events alternatively than directional calls.

The Disconnect Between Market Prices and Analyst Projections

Pfizer presently trades beneath the statement people and supra the bear-case anchors. The banal is up 5.3% twelvemonth to day but inactive trades 32.2% beneath its level from 5 years ago. That terms compression is what makes the income mathematics compelling. Pfizer pays a $0.43 quarterly dividend, supporting a output astir 6.6%, against a backdrop of consecutive years of dividend payments stretching backmost to the Great Depression era.